North America Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Disease Indication (Multiple Sclerosis, Parkinson's Disease, Alzheimer's Disease, Others), By Drug Type (Immunomodulator, Vesicular Monoamine Transporter 2 (VMAT2), Others), By Routes of Administration (Oral, Intravenous (IV) delivery, Others) and By Country (US, Canada) Forecasts, 2026-2034

List of Tables

Table 1: North America North America Neurodegenerative Disease Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 2: North America North America Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 3: North America North America Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 4: North America North America Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 5: US North America Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 6: US North America Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 7: US North America Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 8: Canada North America Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 9: Canada North America Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 10: Canada North America Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)